PLoS ONE (Jan 2011)

Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men.

  • Karim Zouaoui Boudjeltia,
  • Brice Faraut,
  • Maria José Esposito,
  • Patricia Stenuit,
  • Michal Dyzma,
  • Pierre Van Antwerpen,
  • Dany Brohée,
  • Luc Vanhamme,
  • Nicole Moguilevsky,
  • Michel Vanhaeverbeek,
  • Myriam Kerkhofs

DOI
https://doi.org/10.1371/journal.pone.0028230
Journal volume & issue
Vol. 6, no. 11
p. e28230

Abstract

Read online

OBJECTIVES: Many studies have evaluated the ways in which sleep disturbances may influence inflammation and the possible links of this effect to cardiovascular risk. Our objective was to investigate the effects of chronic sleep restriction and recovery on several blood cardiovascular biomarkers. METHODS AND RESULTS: Nine healthy male non-smokers, aged 22-29 years, were admitted to the Sleep Laboratory for 11 days and nights under continuous electroencephalogram polysomnography. The study consisted of three baseline nights of 8 hours sleep (from 11 pm to 7 am), five sleep-restricted nights, during which sleep was allowed only between 1 am and 6 am, and three recovery nights of 8 hours sleep (11 pm to 7 am). Myeloperoxidase-modified low-density lipoprotein levels increased during the sleep-restricted period indicating an oxidative stress. A significant increase in the quantity of slow-wave sleep was measured during the first recovery night. After this first recovery night, insulin-like growth factor-1 levels increased and myeloperoxidase concentration peaked. CONCLUSIONS: We observed for the first time that sleep restriction and the recovery process are associated with differential changes in blood biomarkers of cardiovascular disease.